-
Signature
-
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening
-
Issuer symbol
-
CALX
-
Transactions as of
-
10 Sep 2025
-
Net transactions value
-
-$9,558,160
-
Form type
-
4
-
Filing time
-
11 Sep 2025, 18:33:00 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Weening Michael |
President & CEO, Director |
C/O CALIX, INC., 3155 OLSEN DRIVE, SUITE 450, SAN JOSE |
/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening |
11 Sep 2025 |
0001678385 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$1,176,000 |
+150,000 |
+931% |
$7.84 |
166,117 |
10 Sep 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
$9,300,000 |
-150,000 |
-90% |
$62.00 |
16,117 |
10 Sep 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$62,642 |
+7,990 |
+50% |
$7.84 |
24,107 |
10 Sep 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
$503,370 |
-7,990 |
-33% |
$63.00 |
16,117 |
10 Sep 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Options Exercise |
$141,198 |
+18,010 |
+112% |
$7.84 |
34,127 |
11 Sep 2025 |
Direct |
|
| transaction |
(CALX) |
Common Stock |
Sale |
$1,134,630 |
-18,010 |
-53% |
$63.00 |
16,117 |
11 Sep 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-150,000 |
-33% |
$0.000000 |
300,000 |
10 Sep 2025 |
Common Stock |
150,000 |
$7.84 |
Direct |
F1 |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-7,990 |
-2.7% |
$0.000000 |
292,010 |
10 Sep 2025 |
Common Stock |
7,990 |
$7.84 |
Direct |
F1 |
| transaction |
(CALX) |
Stock Option (right to buy) |
Options Exercise |
$0 |
-18,010 |
-6.2% |
$0.000000 |
274,000 |
11 Sep 2025 |
Common Stock |
18,010 |
$7.84 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.